Welcome to the e-CCO Library!

P487: The feasibility of a digital platform for improving disease management among patients with Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Oddsson, S.(1);Gunnarsdottir, T.(1);Ylanne, K.(2);Molander, P.(3);Thorgeirsson, T.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P487: Tofacitinib for the treatment of ulcerative colitis: Analysis of infection rates from the OCTAVE clinical programme
Year: 2018
Source: ECCO '18 Vienna
Authors:

K.L. Winthrop1, E.V. Loftus Jr.2, D.C. Baumgart3*, W. Reinisch4, A.J. Thorpe5, C.I. Nduaka5, N. Lawendy5, G. Chan5, R.D. Pedersen5, G.S. Friedman5, C. Su5

Created: Thursday, 21 February 2019, 9:14 AM
P488 How reliable is the online medical information on paediatric inflammatory bowel diseases?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Velasco Rodríguez-Belvís1, L.M. Palomino Pérez1, C. Sánchez Fernández-Bravo1, A. Sanchiz Perea2, L.F. Jose Luis1, G. Domínguez Ortega1, E. Cañedo Villarroya1, C.C. Pedrón Giner1, M.P. Jorge1, S. Rodríguez Manchón1, A. Muñoz González1, R.A. Muñoz Codoceo1

Created: Thursday, 30 January 2020, 10:12 AM
P488: Does Statin use reduce the risk of J-pouch related complications in patients with inflammatory bowel disease?
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kaimakliotis P., Lazarev M., Bayless T., Parian A., Brant S., Melia J., Truta B.

Created: Wednesday, 20 February 2019, 10:36 AM
P488: Efficacy of pre-operative oral antibiotic prophylaxis for the prevention of wound infections in patients with Crohn's disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Uchino*, H. Ikeuchi, T. Bando, T. Chohno, H. Sasaki, Y. Horio, R. Kuwahara, T. MInagawa

Created: Thursday, 21 February 2019, 9:14 AM
P488: IBS-type symptoms in patients with quiescent inflammatory bowel disease are unrelated to ongoing inflammation
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

D. Hoekman*1, J. Zeevenhooven2, G. D’Haens3, M. Benninga1

Created: Friday, 22 February 2019, 9:49 AM
P488: Perianal Crohn's disease in the biological era
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

F. Pires*1, A. Carvalho1, D. Martins1, E. Cancela1, A. Silva1, P. Ministro1

Created: Friday, 22 February 2019, 9:41 AM
P488: Switch from intravenous to subcutaneous infliximab in patients with Inflammatory Bowel Disease: efficacy, safety and patients' acceptance
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Caballol Oliva, B.(1)*;Fernàndez-Clotet, A.(2);Panés, J.(2);Masamunt, M.C.(2);Gallego, M.(2);Barastegui, R.(2);Vara, A.(2);Giner, À.(2);Ricart, E.(2);Ordás, I.(2);
Created: Friday, 14 July 2023, 11:05 AM
P488: The COVID19 pandemic impact on Inflammatory Bowel Disease Patients Management in a Romanian Tertiary Gastroenterology Centre
Year: 2021
Source: ECCO'21 Virtual
Authors: Costache, R.(1);Iacob, R.(1);Vadan, R.(1);Stroie, T.(1);Gheorghe, L.(1);Diculescu, M.(1);Gheorghe, C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P488: Trends in corticosteroid (CS) use over time and following diagnosis in patients with Inflammatory Bowel Disease (IBD), using IBM® MarketScan®
Year: 2022
Source: ECCO'22
Authors: Raine, T.(1);Melmed, G.Y.(2);Finney-Hayward , T.(3);Clark, R.(4);Chapman, J.C.(5);Targownik, L.(6);Burisch, J.(7);Olen, O.(8);
Created: Friday, 11 February 2022, 3:56 PM
P489 Are patients with inflammatory bowel disease receiving an adequate immunisation?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Simian1, P. Núñez2, L. Flores1, C. Figueroa1, P. Ibáñez1, U. Kronberg1, J. Lubascher1, G. Pizarro1, R. Quera1

Created: Thursday, 30 January 2020, 10:12 AM
P489: Clinical experience with ustekinumab in selected Crohn's disease patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Saman*, T. Klag, J. Wendler, M. Goetz, N.P. Malek, J. Wehkamp

Created: Thursday, 21 February 2019, 9:14 AM
P489: Defective anti-microbial peptides expression in Crohn’s disease mucosa can be reversed by strengthening IL-22 signalling
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Fantou*1,2, J. Martin1,2, A. Jarry3, A. Bourreille4,5, R. Josien1,2

Created: Friday, 22 February 2019, 9:41 AM
P489: Double-dose infliximab therapy in Crohn's disease: appropriate time to evaluate the efficacy, long-term efficacy and safety
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kunisaki R., Nishio M., Ogashiwa T., Otake H., Inoue E., Kimura H.

Created: Wednesday, 20 February 2019, 10:36 AM
P489: Predicting mucosal state with faecal calprotectin in children with Crohn’s disease.
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Meglicka*1, M. Szczepanski2, M. Dadalski2, J. Kierkus2

Created: Friday, 22 February 2019, 9:49 AM
P489: Rescue treatment with original versus biosimilar infliximab in biologic-naïve patients with moderate-severe Ulcerative Colitis and corticosteroid failure
Year: 2021
Source: ECCO'21 Virtual
Authors: Muñoz-Villafranca, C.(1);Ogueta, M.Á.(2);Ramírez de la Piscina, P.(2);Álvarez-Herrero, B.(2);Loizate, A.(3);Gómez-Zabala, J.M.(3);De La Maza-Ortiz, S.(1);Aresti, U.(4);Gorostiza, I.(4);Arreba, P.(1);Irigoyen, M.(5);Ortiz de Zárate, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P489: Surgery for enterocutaneous fistula: the strongest predictor of postoperative mortality in Crohn's disease patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Iesalnieks, I.(1)*;Adamou, A.(2);Magdalena, B.(2);
Created: Friday, 14 July 2023, 11:05 AM
P489: Temporal trends of colectomy for ulcerative colitis in the multi-drug era; a population based cohort study.
Year: 2022
Source: ECCO'22
Authors: Jenkinson, P.(1);Plevris, N.(1);Lyons, M.(1);Gros, B.(1);Derikx, L.(1);Constantine-Cooke, N.(1);Jones, G.(1);Lees, C.(1);
Created: Friday, 11 February 2022, 3:56 PM
P490 Assessment of body weight changes in patients with inflammatory bowel diseases initiating biologic therapy: A prospective cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Borren, W. Tan, A. Jess, P.H.M. Li, J. Garber, J. Luther, F. Colizzo, H. Khalili, A. Ananthakrishnan

Created: Thursday, 30 January 2020, 10:12 AM
P490: A pilot study of the electronic patient portal “Patient Knows Best” for monitoring biologic therapy in inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kamperidis N., O'Connor M., Crook K., Arebi N.

Created: Wednesday, 20 February 2019, 10:36 AM